Register
Login:
Share:
Email Facebook Twitter




Add Verona Pharma to quick picks

Verona Pharma Share Price (VRP)



Share Price Information for Verona Pharma (VRP)


Share Price: 4.925Bid: 4.75Ask: 5.10Change: 0.00 (0.00%)No Movement on Verona Pharma
Spread: 0.35Spread as %: 7.37%Open: 4.55High: 5.05Low: 4.55Yesterday’s Close: 4.925

Verona Pharma Plc Ord 0.1P

Verona Pharma is listed in the FTSE AIM All-Share
Verona Pharma is part of the Pharmaceuticals & Biotechnology sector






Share Price SpacerPrice
4.925

Share Price SpacerBid
4.75

Share Price SpacerAsk
5.10

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
1,650,358

Share Price SpacerOpen
4.55

Share Price SpacerHigh
5.05

Share Price SpacerLow
4.55

Share Price SpacerClose
4.925

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 1,009.92m £49.74m 30,000

52 Week High 6.88 52 Week High Date 12-JUN-2015
52 Week Low 1.05 52 Week Low Date 31-OCT-2014

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
37 466,760 1,005,833 -15.391 -0.32 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

28-Aug-15
16:27:14
4.95
100,707
Buy* 
4.75
5.10
4,985
Trade Type:
Ordinary

28-Aug-15
16:05:55
4.873
10,000
Sell* 
4.75
5.10
487.30
Trade Type:
Ordinary

28-Aug-15
15:57:03
4.95
19,960
Buy* 
4.75
5.10
988.02
Trade Type:
Ordinary


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Verona Pharma trades >>

Directors Deals for Verona Pharma (VRP)
Trade DateActionNotifierPriceCurrencyAmountHolding
07-Jul-15Transfer To
Trade Notifier Information for Verona Pharma
Stuart Bottomly held the position of Non-Executive Director at Verona Pharma at the time of this trade.
 Stuart Bottomly
0500,00019500000
17-Jun-15Buy
Trade Notifier Information for Verona Pharma
David Ebsworth held the position of Non-Executive Chairman at Verona Pharma at the time of this trade.
 David Ebsworth
4.7GBX250,0003829774
18-May-15Buy
Trade Notifier Information for Verona Pharma
David Ebsworth held the position of Non-Executive Chairman at Verona Pharma at the time of this trade.
 David Ebsworth
3.5GBX300,0003579774
View more Verona Pharma directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Fri 19:02
bewise
Vrp
4.93
Strong Buy

Good finish! Roll on September :)
Fri 10:56
layercake
unfortunately
5.00
No Opinion

it's a dead cat bounce. Tried a sell and already down to 4.75 bid. Roll on Sept with hopefully good results.
Fri 09:53
brodie75
Sp
5.05
No Opinion

Really good start to the morning,let's see if we can maintain I throughout the day and move forward now in an upward fashion.gla
Fri 09:44
Vicmy
good to see
5.05
No Opinion

that VRP has made it on the top risers board today. There is plenty of potential in this company IMO.
Fri 09:39
Vicmy
With the
5.05
No Opinion

value of the work they are implementing, I would have thought VRP would have been rerated to at least 6p by now. GLA!
Fri 09:28
bewise
vrp
4.95
Strong Buy

Sp up 12% back over 5; those who added in the 4's did well, those who sold imo was premature! September is a big month for us!

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Verona Pharma (VRP) >>
Please Login or Register to post messages






Sign up for Live Prices




Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.